{
    "code": "01014560",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01014560",
    "time": "2015-08-22 20:14:13",
    "許可證字號": "衛署藥製字第014560號",
    "廢止狀態": "已廢止",
    "廢止日期": "",
    "廢止理由": "",
    "有效日期": "97\/11\/14",
    "發證日期": "67\/03\/28",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00101456001",
    "中文品名": "康那宗錠",
    "英文品名": "CONAZONE TABLETS",
    "適應症": "頭痛、關節痛、風濕關節痛、偏頭痛、生理痛、肌肉痛、手術後疼痛、牙痛、感冒、一般解熱、鎮咳、上氣道感染、拔齒等之疾患",
    "劑型": "110錠劑",
    "包裝": "100,500,1000錠瓶裝 100,500,1000錠盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "EPHEDRYL ISOPROPYLANTIPYRINE (EIA), ETHENZAMIDE (ETHOXYBENZAMIDE), HYDROXYBUTYRIC ACID BETA- P-PHENETIDIDE (BUCETIN)",
    "限制項目": [
        "01國產",
        "09委託製造"
    ],
    "申請商名稱": "0906402200  恆信藥品有限公司",
    "申請商地址": "台北市松山區復興北路1號6樓之6",
    "主製造廠": {
        "製造廠名稱": "1103310300  健康化學製藥股份有限公司",
        "製造廠廠址": "台中市大甲區幼獅工業區幼四路１２號",
        "製造廠公司地址": "",
        "製造廠國別": "TAIWAN",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2808202200",
            "成分名稱": "EPHEDRYL ISOPROPYLANTIPYRINE (EIA)",
            "含量描述": "",
            "含量": "30.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2808600900",
            "成分名稱": "ETHENZAMIDE (ETHOXYBENZAMIDE)",
            "含量描述": "",
            "含量": "100.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "4040000412",
            "成分名稱": "HYDROXYBUTYRIC ACID BETA- P-PHENETIDIDE (BUCETIN)",
            "含量描述": "",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ]
}